Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
for Solid Tumor
7 locations incl. Scottsdale
Sponsor: Alyssum Therapeutics
Sex: All·Age: 18+
Code: NCT06234098·Phase 1, Phase 2·Recruiting·Listed Jan 2024